chrX-120626901-G-A
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_001011551.3(C1GALT1C1):c.266C>T(p.Thr89Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 23)
Consequence
C1GALT1C1
NM_001011551.3 missense
NM_001011551.3 missense
Scores
7
7
3
Clinical Significance
Conservation
PhyloP100: 9.56
Genes affected
C1GALT1C1 (HGNC:24338): (C1GALT1 specific chaperone 1) This gene encodes a type II transmembrane protein that is similar to the core 1 beta1,3-galactosyltransferase 1, which catalyzes the synthesis of the core-1 structure, also known as Thomsen-Friedenreich antigen, on O-linked glycans. This gene product lacks the galactosyltransferase activity itself, but instead acts as a molecular chaperone required for the folding, stability and full activity of the core 1 beta1,3-galactosyltransferase 1. Mutations in this gene have been associated with Tn syndrome. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.962
PP5
Variant X-120626901-G-A is Pathogenic according to our data. Variant chrX-120626901-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 2506572.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C1GALT1C1 | NM_001011551.3 | c.266C>T | p.Thr89Ile | missense_variant | 2/2 | ENST00000304661.6 | |
C1GALT1C1 | NM_152692.5 | c.266C>T | p.Thr89Ile | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C1GALT1C1 | ENST00000304661.6 | c.266C>T | p.Thr89Ile | missense_variant | 2/2 | 1 | NM_001011551.3 | P1 | |
C1GALT1C1 | ENST00000371313.2 | c.266C>T | p.Thr89Ile | missense_variant | 3/3 | 1 | P1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Atypical hemolytic-uremic syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | research | The Morris Kahn Laboratory of Human Genetics, Ben-Gurion University of the Negev | Jun 24, 2023 | A de novo C1GALT1C1:c.266C>T;p.Thr89Ile variant was identified in a patient exhibiting early-onset atypical hemolytic uremic syndrome (aHUS), and was not present in the gnomAD database. This variant is situated in an area of remarkable evolutionary conservation. In vitro studies have demonstrated that this variant results in the generation of an exposed T-antigen on erythrocytes, which incites complement activation against these erythrocytes (Noam Hadar et al. 2023). This action potentially mirrors the mechanism of T-antigen mediated pneumococcal hemolytic uremic syndrome (Nicolas Burin des Roziers et al. 2015). In conclusion, the de novo Thr89Ile variant was absent from control samples, and the molecular mechanism it underlies leads to the exposure of a T-antigen in a manner similar to that observed in pneumococcal hemolytic uremic syndrome. Consequently, this variant is classified as pathogenic. - |
Hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 11, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;D
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;T
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Pathogenic
Sift
Uncertain
D;D
Sift4G
Benign
T;T
Polyphen
D;D
Vest4
MutPred
Gain of methylation at K92 (P = 0.0443);Gain of methylation at K92 (P = 0.0443);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.